期刊文献+

调节性T细胞在川崎病免疫学发病机制中的作用研究 被引量:3

The Role of Regulatory T Cells in Immunological Pathogenesis of Kawasaki Disease
下载PDF
导出
摘要 目的:探讨CD4+CD25+调节性T细胞、CD4+CD25+Foxp3+调节性T细胞及其他免疫细胞在川崎病(KD)免疫学发病机制中的作用。方法:选取急性期KD患儿58例,其中31例无冠状动脉损害(CAL),27例有CAL,另选取同期健康儿童30例作为对照组。采用流式细胞仪测定外周血CD4+CD25+调节性T细胞、CD4+CD25+Foxp3+调节性T细胞及其他免疫细胞比例并分析其变化规律。结果:急性期KD患儿外周血中,CD4+CD25+、CD4+CD25+Foxp3+、CD3+CD8+、CD3-CD(16+56+)细胞比例明显降低,CD4+/CD8+、CD19+CD23+、CD3-CD19+细胞亚群比例明显增高(P均<0.01)。无CAL的KD患儿与有CAL的KD患儿调节性T细胞亚群比较差异无统计学意义(P>0.05)。结论:KD急性期存在免疫调节功能紊乱,可能与CD4+CD25+调节性T细胞和CD4+CD25+Foxp3+调节性T细胞减少密切相关。 Objective: To investigate the role of CIM+CD25+ regulatory T cells, CD4+ CD25* Foxp3+ regulatory T cells and the other immune cells subsets in immunological pathogenesis of Kawasaki disease (KD). Methods: Total 58 children with KD were enrolled in KD group, including 27 cases with coronary artery lesion (CAL) and 31 cases without coronary artery lesion (non-CAL), 30 agematched health children were included in control group. Applying flow cytometer (FCM) to determine the proportion of CD^4+ CD25+ regulatory T ceils, CD4+ CD25 + Foxp3 + regulatory T cells and the other immune cells subsets. Results: The proportion of CD4+ CD25 + regulatory T cells and CD^4+CD25+ Foxp3+, CD3+CD8+, CD3-CD( 16+56+) cells in peripheral blood from children with KD at acute phase were significantly lower than those of control group ( P〈0.01 ). The proportion of CD4+/CD8+, CD19+ CD23+, CD3- CD19+ increased significantly. There was no statistical difference between the proportion of immune cells subsets from cases with CAL and cases with non-CAL. Conclusion: Immune dysfunction is involved in the acute stage of KD, the decrease of CD4+ CD25+ and CD4+ CD25+ Foxp3+ regulatory T cells may be correlated with this.
出处 《儿科药学杂志》 CAS 2015年第5期7-9,共3页 Journal of Pediatric Pharmacy
关键词 CD4+CD25+ CD4+CD25+Foxp3+ 调节性T细胞 川崎病 CD4+CD25+ CD4+CD25+Foxp3+ Regulatory T cells Kawasaki disease
  • 相关文献

参考文献17

  • 1Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease ( the 5'h revised edition ) [ J ]. Pediatr Int, 2005, 47 (2) : 232-234.
  • 2黄滢,吴柱国.川崎病发病机制的研究现状[J].广东医学院学报,2010,28(1):57-61. 被引量:9
  • 3Rowley AH, Shulman ST. Pathogenesis and management of Kawasaki disease [ J ]. Expert Rev Anti Infect Ther, 2010, 8 (2) : 197-203.
  • 4刘芳.川崎病的病因及发病机制研究进展[J].实用儿科临床杂志,2011,26(21):1617-1618. 被引量:25
  • 5Yim D, Curtis N, Cheung M, et al. Update on Kawasaki disease : Epidemiology, aetiology and pathogenesis [ J ]. Journal of Paediatrics and Child Health, 2013, 49(9) : 704-708.
  • 6Ehara H, Kiyohara K, Izumisawa Y, et al. Early activation does not translate into effector differentiation of peripheral CD8 T cells during the acute phase of kawasaki disease [ J ]. Cellular Immunology, 2010, 265(1) : 57-64.
  • 7GiordaniL, Quaranta MG, Marchesi A, et al. Increased frequency of immunoglobulin (Ig) A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with kawasaki disease [J]. Clin Exp Immunol, 2011, 163(3) : 346-353.
  • 8Ramedell F, Ziegler SF. Transcription factor in autoimmunity[J]. Current Opinion in Immunology, 2003, 15(6) : 718-724.
  • 9Seo N, Yamashiro H, Tadaki T. Anti-infective and anti-tumor agents based on the depletion of immune suppressive effects [ J]. Curt Med Chem, 2008, 15 (10) : 991-996.
  • 10Langier S, Sade K, Kivity S. Regulatory T cells: the suppressor arm of the immune system [ J ]. Autoimmun Rev, 2010, 10 (2) : 112-115.

二级参考文献110

共引文献61

同被引文献26

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部